You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《滬深兩市》A股三大指數以全日低位收市 上證失守2,900點 藥明康德連續兩日跌停
內地去年工業企業利潤按年跌2.3%,上月增16.8%連增五個月。中國證監會經充分論證評估,暫停限售股出借,對融券效率進行限制。人民銀行今日進行5,000億元人民幣(下同)七天期逆回購操作,中標利率持平於1.8%。今日單日淨投放3,780億元。人民幣兌美元中間價今下調13點,報7.1097。 A股三大指數早前反覆個別發展,上證反覆靠穩,深成創板低開低走。A股三大指數午後缺乏承接,上證倒跌收市失守2,900點關,深成創板跌幅擴大至2%至逾3%,均以全日低位收市。 滬指全日收報2,883點,跌0.9%,成交額3,970億元。深成指收報8,581點,跌2%,成交額4,082億元。創業板收報1,623點,跌3.5%,成交額1,627億元。 中資金融股逆市偏好,建行(601939.SH)升0.9%。工行(601398.SH)升1.4%。 三大電訊股逆市有支持,惟下午升幅顯著收窄。中移動(600941.SH)、中電信(601728.SH)及中國聯通(600050.SH)升0.4%-1.4%。 三桶油先升後個別發展,中石油(601857.SH)及中海油(600938.SH)分別跌1.2%及0.2%。中石化(600028.SH)則升1.9%。 內房股反覆走個別,保利發展(600048.SH)微升0.8%。萬科(000002.SZ)及金地集團(600383.SH)分別跌1.4%及2.5%。廣州放寬限購政策,支持房地產項目合理融資需求。法院終頒令恆大(03333.HK)清盤,影響市場對內房信心。 比亞迪(002594.SZ)及寧德時代(300750.SZ)分別跌4%及2%。隆基綠能(601012.SH)低開低走挫7.1%,公司指光伏產業鏈價格降至非常不理性位置。 藥明康德(603259.SH)續跌停。就市傳美中特別委員會提議禁止華大基因(300676.SZ)及藥明康德等外國生物公司,藥明康德上周五晚(26日)急開投資人電話會議,重申業務發展不對任何國家安全構成風險,其後再發公告澄清,指公司始終堅持「做對的事 把事做好」,生物安全法草案涉及公司內容既不恰當也不準確。華大基因亦再跌2.5%。(ta/cy) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account